Bioprosthetic aortic valve replacement in <50 years old patients - where is the evidence?
Rev. bras. cir. cardiovasc
;
34(6): 729-738, Nov.-Dec. 2019. tab
Article
in English
| LILACS
| ID: biblio-1057506
ABSTRACT
Abstract Aortic valve disease is one of the most common valvular heart diseases in the cardiovascular category. Surgical replacement of the diseased aortic valve remains the definitive intervention for most diseases. There is a clear consensus that in young patients who require aortic valve replacement, a mechanical prosthesis is the preferred choice due to its durable prosthesis without fear of wear and tear over time. However, this comes at the expense of increased risk of bleeding and thromboembolic events; in addition, there is a lack of strict evidence in using bioprosthesis in patients younger than 50 years. The objective of this review article is to assess the current evidence behind using bioprosthetic aortic valve in this young cohort.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Aortic Valve
/
Bioprosthesis
/
Heart Valve Prosthesis
/
Heart Valve Prosthesis Implantation
/
Heart Valve Diseases
Type of study:
Etiology study
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Rev. bras. cir. cardiovasc
Journal subject:
Cardiology
/
General Surgery
Year:
2019
Type:
Article
Affiliation country:
China
/
United kingdom
Institution/Affiliation country:
Liverpool Heart and Chest Hospital/GB
/
Manchester Royal Infirmary/GB
/
The Chinese University of Hong Kong/CN
Similar
MEDLINE
...
LILACS
LIS